Jupiter Life Line Hospitals Ltd. JLHL
NSE · India · Health Services
INR 259.85+6.25 (+2.46%)
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · INR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Jupiter Life Line Hospitals Ltd (NSE:JLHL) reports a 19.3% EBITDA margin with a INR 9.5 crore drag from its new Dombivali facility, while maintaining a zero net debt position.
Jupiter Life Line Hospitals Ltd (NSE:JLHL) reports a 15.2% increase in total income and outlines ambitious expansion plans despite facing cost pressures.
Jupiter Life Line Hospitals Ltd (NSE:JLHL) reports revenue growth and strategic expansion, despite facing short-term financial pressures from new hospital developments.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.